Labs across the globe have mobilized in historic fashion to try to find a treatment for COVID-19. Scott Pelley reports on which therapeutics are causing optimism.
Now working on monoclonal antibodies to treat COVID-19, the virologist gained recognition in the 1990s for treating Magic Johnson. He first appeared on 60 Minutes in 1998.
The infusion of a monoclonal antibody cocktail to treat the virus that causes COVID represents a true advance in both treatment and prevention of SARS-CoV-2 infection.
Dr. David Ho, scientific director and CEO of the Aaron Diamond AIDS Research Center, talks about Regeneron, the experimental antibody cocktail that Donald Trump was given as treatment for Covid-19.
The United States is now looked upon by countries in Europe with incredulity and alarm as the pandemic continues rage with the US leading the world in cases and deaths.
Regeneron, Eli Lily, and Astra Zeneca are among a number of major pharmaceutical companies testing neutralizing antibody cocktails to treat and prevent SARS-CoV-2 infection.
Dr. David Ho joins Meg Tirrell on CNBC’s “Healthy Returns: The Path Forward”. He discusses the SARS-CoV-2 pandemic and the work of his research team at the Aaron Diamond Aids Research Center.
A study recently published in Nature by Dr. David Ho and his team at Columbia University identified a mix of 19 different antibodies that target SARS-CoV-2, the coronavirus that causes COVID-19.
A panel of experts summarize advances in treatments and preventative strategies to address the SARS-CoV-2 pandemic and shre views on the dire situation in the US during the surge in infections.
